MedicaMetrix

Early Stage

Invest in the Future of Prostate Health

Analytics

Platform

Self Managed

Start Date

09/13/2021

Close Date

09/12/2022

Min. Goal

$250

Max. Goal

$20,000,000

Min. Investment

$250

Security Type

Equity - Common

Funding Type

RegA+

Series

Series B

Pre-Money Valuation

$20,000,000

Location

Lowell, Massachusetts

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Business Type

Growth

MedicaMetrix is raising funds independently through Reg A+ crowdfunding. The company aims to provide medical technologies and products to improve health and quality of life for people with chronic diseases. MedicaMetrix currently has two products that it plans to commercialize in the future. ProstaMetrix will be used to measure prostate volume to evaluate the size of a patient’s prostate gland, and SureSet is a single-use intravascular catheter. Robert Rudelius and Satish Vankayalapati founded MedicaMetrix in 2020. The current crowdfunding campaign has no minimum target and a maximum target of $20,000,000. The campaign proceeds will be used for product development, refinement, and additional trials, regulatory filings, global business development and marketing, and management compensation.

Balance Sheet

Cash and Cash Equivalents

$2,729,996

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$88,000

Loans

$0

Property, Plant and Equipment (PP&E)

$11,400

Property and Equipment

$0

Total Assets

$2,829,752

Accounts Payable & Accrued Liabilities

$424,699

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$0

Total Liabilities

$424,699

Total Stockholders' Equity

$2,405,053

Total Liabilities and Equity

$2,829,752

Statement of Comprehensive Income Information

Total Revenues

$0

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$1,017,987

Total Interest Expenses

$0

Depreciation and Amortization

$1,330

Net Income

$-1,017,987

Earnings Per Share - Basic

$0

Earnings Per Share - Diluted

$0

Auditor: Marcum LLP
Financials as of: 09/13/2021
Log in or create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Starter

$8.33 /month
billed annually
Free portfolio tracking. Limited reports and filters.
Plan Includes:
Everything in Free, plus
Advanced company search ( limited filters)
Founder profiles and exclusive webinars
2 Analyst Reports per month
Get Starter Annual

Pro

$25 /month
billed annually
Unlimited analyst reports and market analytics.
Plan Includes:
Everything in Starter, plus
Full access to all Analyst Reports
Filter on Analyst Reports (e.g. Top Deal, Deal to Watch, etc.)
Market Analytics
Get Pro Annual

Merlin

$41.67 /month
billed annually
Full site access including Merlin ratings.
Plan Includes:
Everything in Pro, plus
Search and filter companies by Merlin ratings
Company specific Merlin rating and risk assessment
Get Merlin Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
MedicaMetrix on Self Managed 2021
$
Platform: Self Managed
Security Type: Equity - Common
Valuation: $20,000,000

Follow company

Follow MedicaMetrix on Self Managed 2021